Hypertension

Integration of a task strengthening strategy for hypertension management into HIV care in Nigeria: Baseline characteristics of participants in a cluster randomized controlled trial

Am Heart JPublished cluster randomized controlled trial

Authors' conclusion

The prevalence of hypertension among PLWH was higher than previously reported. Although most participants adopted healthy lifestyle behaviors, the majority were overweight or obese, and many were not on antihypertensive medications. These findings highlight the importance of integrating hypertension control into HIV care across PHCs in Nigeria.

Study context

Population
People living with HIV on antiretroviral therapy attending primary health centers in Lagos, Nigeriaenrolled, 3,504 screened in 30 primary health centers (PHCs)
Participants
830 people
Comparison
2 implementation strategies for integrating TASSH into HIV care
Methodological detailsbaseline characteristics report, 30 PHCs in Lagos, Nigeria
  • Baseline characteristics report
  • 30 PHCs in Lagos, Nigeria

Primary result

As reported in the abstract

Hypertension prevalence among screened · baseline

Had hypertension, of the 3,504 screened

1,046

29.9%

Further findings

Baseline characteristics of the 830 enrolled

Age, mean [SD]
49.4 [9.5] years
Women
63.5%
At least secondary school education
69.5%
Employed
92.3%
Earned less than 100,000 Naira (64.74 USD) monthly
84.6%
Median BP
150.0/95.3 mmHg
Overweight or obese
63.9%
Continued previously prescribed antihypertensive medications
25.8%
Received new prescriptions
66.3%
Alcohol users
25.1%
Current smokers
1.8%
Physically inactive
30.9%

Original publication

Integration of a task strengthening strategy for hypertension management into HIV care in Nigeria: Baseline characteristics of participants in a cluster randomized controlled trial. Am Heart J. Published 17 February 2026. doi:10.1016/j.ahj.2026.107383

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.